Piqray plus Faslodex significantly improved PFS in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast ...

Dr. Ariel Ostad sat down with CURE to discuss the often-overlooked emotional and practical challenges that patients face ...

Consuming more sugar does not feed cancer cells, but the concern is that it does cause inflammation in the body if you're eating excess sugar in your diet. It is those inflammatory changes that are ...

Joe McDonough sat down for an interview with CURE to share his family’s story and the inspiration behind the B+ Foundation.

Oya Gilbert, a 55-year-old who was diagnosed with multiple myeloma in 2017, encourages newly diagnosed patients, especially ...

For patients with blood cancer, it is crucial to own their own cancer journey, as a five-time cancer survivor and author ...

Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...

For nearly a decade, Mayra Andujar-Delgado has navigated the complexities of living with myelofibrosis, a journey she says was fundamentally shaped by the steady, compassionate guidance of her ...

CURE spoke with Patricia I. Moreno, who holds a Ph.D. and is a licensed clinical psychologist and lead of evidence-based ...

Orserdu combined with Afinitor or Verzenio shows favorable tolerability and progression-free survival in ER-positive, ...

Lynozyfic (linvoseltamab), a B-cell maturation antigen and CD3 bispecific antibody, showed a high overall response rate and a ...

Trodelvy showed fewer severe side effects and required fewer dose reductions or discontinuations compared to chemotherapy in ...